Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11655455 Enhanced systems for cell-mediated oncolytic viral therapy

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Calidi Biotherapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

May 23, 2023

0

Patent Application Number

166764130

Date Filed

November 6, 2019

0

Patent Citations

US Patent 7537924 Virus strains

0

US Patent 7550296 Generation of replication competent viruses for therapeutic use

0

US Patent 7588767 Microorganisms for therapy

0

US Patent 7645456 Vaccinia virus strains

0

US Patent 7662627 Adeno-associated virus materials and methods

0

US Patent 7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

0

US Patent 7731974 Mutant vesicular stomatitis viruses and uses thereof

0

US Patent 7754221 Microorganisms for therapy

0

...

Patent Primary Examiner

0

Provided herein are enhanced systems for potentiating cell-mediated oncolytic viral therapy. Also provided are modified viruses for such systems, and methods of treatment of cancers by administering such systems.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11655455 Enhanced systems for cell-mediated oncolytic viral therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool